Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation

Hepatic Veno-Occlusive Disease Clinical Trial

Official title:
Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation

Status Active, not recruiting

Clinical Trial Summary

To evaluate efficacy and safety of AT-III treatment in patients with hepatic veno-occlusive diseases following hematopoietic stem cell transplantation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hepatic Veno-Occlusive Disease

Clinical Trial Details

NCT number	NCT01886248
Study type	Interventional
Source	Seoul National University Hospital
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	June 2013
Completion date	August 2021

View Details

See also
Status	Clinical Trial	Phase
No longer available	`NCT00143546` - Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver	N/A
Recruiting	`NCT00563498` - Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients	N/A
Not yet recruiting	`NCT04168788` - Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL	N/A
Completed	`NCT00628498` - Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study	Phase 3
Completed	`NCT00272948` - Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide	Phase 2/Phase 3
Completed	`NCT03032016` - European VOD Registry